DOCSLIB.ORG

Cutaneous Squamous Cell Carcinoma with Perineural Invasion: a Case Report and Review of the Literature

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Cutaneous Squamous Cell Carcinoma with Perineural Invasion: a Case Report and Review of the Literature Cutaneous Squamous Cell Carcinoma With Perineural Invasion: A Case Report and Review of the Literature Chad C. Adams, MD; Brian Thomas, MD; Jonathan L. Bingham, MD Practice Points Patients with suspected cutaneous squamous cell carcinoma should be asked about neurological symp- toms including pain, loss of motor skills, anesthesia, dysesthesia, and/or paresthesia, which may indicate perineural invasion. Patients with perineural invasion carry a much higher risk for local and distant recurrence and may require more aggressive treatment including Mohs micrographic surgery and adjuvant radiation. Perineural invasion (PNI) is an uncommon man- or muscle weakness of the face as well as any loss or ifestation of cutaneous squamous cell carci- change in vision. noma (SCC). We report CUTISa case of recurrent Physical examination revealed a well-healed cutaneous SCC with PNI diagnosed both clini- advancement flap scar with induration at the medial cally and histologically. We also provide a review border (Figure 1). Biopsy results were positive for recur- of the literature. Clinicians should be aware of rent SCC. Based on anatomic location, clinical symp- this uncommon finding, as PNI has been associ- toms, and tumor recurrence, treatment with MMS ated with increased local recurrence, local and was initiated. Mohs sections demonstrated perineural distant metastasis, and poor prognosis. Patients invasion (PNI)(Figures 2 and 3). Multiple treatment withDo clinical findings associated Not with perineural stages wereCopy required for tumor clearance following the involvement have a poorer prognosis than those retrograde course of a nerve, which resulted in a sub- incidentally discovered on histologic examination, stantial defect (Figure 4). The defect was allowed to which emphasizes the importance of a thorough heal by second intention followed by radiation therapy. history and neurologic examination in patients with cutaneous SCC to identify those who will Comment require more aggressive therapy. Incidence and Pathogenesis—Perineural invasion was Cutis. 2014;93:141-144. first described by Cruveilhier1 in a report of invasion of the facial nerve in a patient with mammary carcinoma. Case Report Neumann2 reported the first case of a primary cutane- A 74-year-old man with a history of squamous cell ous lesion exhibiting PNI in a patient with a primary carcinoma (SCC) on the right side of the temple that carcinoma of the lower lip with invasion and spread was treated with Mohs micrographic surgery (MMS) along the mental nerve. Perineural invasion is seen in 3 years prior presented with a burning and tingling approximately 5% of 200,000 total cases of cutaneous sensation of 3 months’ duration in the medial border SCC reported annually in the United States.3,4 Other of the repair scar. The patient denied prior anesthesia malignancies exhibit PNI more frequently, such as microcystic adnexal carcinoma of the skin, which has Dr. Adams is from Uniformed Services University of the Health been reported to have an 80% rate of perineural growth.5 Sciences, Bethesda, Maryland. Drs. Thomas and Bingham are from Perineural invasion can involve nerves of vari- Walter Reed National Military Medical Center, Bethesda. The authors report no conflict of interest. able thickness, but invasion of larger nerves typically 6 Correspondence: Chad C. Adams, MD, 2903 Ivydale St, Silver Spring, portends a poorer prognosis. Characteristics of cuta- MD 20902 ([email protected]). neous SCC that predispose the lesion to PNI include WWW.CUTIS.COM VOLUME 93, MARCH 2014 141 Copyright Cutis 2014. No part of this publication may be reproduced, stored, or transmitted without the prior written permission of the Publisher. SCC With Perineural Invasion Figure 1. Recurrent cutaneous squamous cell carcinoma on the right side of the temple that was treated with Mohs micrographic surgery 3 years prior to presenta- tion, which resulted in a scar. Figure 3. A large peripheral nerve (diameter, 0.1 mm) in cross-section with perineural and intraneural carci- noma was evident. An associated lymphocytic inflam- matory infiltrate was present around the nerve bundle (H&E, original magnification 10). CUTIS Figure 2. A large peripheral nerve (diameter, 0.1 mm) demonstrated an intraneural island of enlarged,Do atypical keratinocytes Notthat formed keratin Copy eddies. A lymphocytic infiltrate surrounded the peri- neurium (H&E, original magnification 10). size greater than 2 cm, male gender, location on the face, and prior treatment of the lesion.6,7 In a study Figure 4. Multiple stages of Mohs micrographic sur- gery resulted in a substantial defect. of cutaneous SCC, Leibovitch et al7 found PNI in 4.7% (36/772) of primary lesions and 6.9% (34/491) of recurrent lesions. In another study of 180 SCC tumors of the head and neck with PNI, Carter et al8 found molecules may be a factor in determining the meta- that PNI was most commonly seen in tumors that were static potential of cutaneous SCCs and that levels of greater than 2.5 cm, suggesting that larger lesions have neurotrophic tyrosine kinase receptor type 1 (TrkA) an increased predisposition for PNI. may predict PNI, but their study results lacked statisti- The mechanism(s) by which PNI develops from cal power to form a firm conclusion. these malignancies has not been fully elucidated, but Diagnosis and Prognosis—Perineural invasion can be some clues have been found. Vural et al9 showed a sta- diagnosed clinically, radiologically, or microscopically. tistically significant difference (P.01) in expression On clinical examination, PNI is suggested by findings of neural cell adhesion molecules with 93% (38/41) of neuropathy most frequently in cranial nerves V of SCCs with PNI showing evidence of expression and/or VII, likely due to their extensive subcutaneous versus 36% (9/25) of SCCs without PNI. Chen-Tsai distribution.11 Common symptoms include pain, loss of et al10 also suggested that levels of neural cell adhesion motor skills, anesthesia, dysesthesia, and/or paresthesia 142 CUTIS® WWW.CUTIS.COM Copyright Cutis 2014. No part of this publication may be reproduced, stored, or transmitted without the prior written permission of the Publisher. SCC With Perineural Invasion (ie, tingling, burning, pricking, numbness).12,13 In a Prognosis also is altered by the diameter of the study of 72 cases, Goepfert et al14 found that only nerve involved. In a study of 48 patients, Ross et al23 40% (29/72) of patients with pathologically confirmed found that patients with cutaneous SCC involv- PNI presented with clinical symptoms and these ing small-caliber nerves (diameter, ≤0.1 mm) had a patients had a poorer prognosis. 0% disease-specific death rate versus 32% in those with Radiologically, PNI can be identified via computed large-caliber nerves (0.1 mm). Perineural involve- tomography or magnetic resonance imaging through ment of small-caliber nerves (0.1 mm) was a posi- findings of enlargement or abnormal enhancement tive prognostic indicator in that it was associated with of the nerve, obliteration of the normal fat plane sur- smaller tumor diameter, more shallow invasion, and rounding the nerve, or erosion or enlargement of its increased likelihood to be primary tumors.23 In a recent related foramen.15 Magnetic resonance imaging is the study, Jambusaria-Pahlajani et al24 investigated tumor preferred method for assessing enhancement of the staging for cutaneous SCC and reported that PNI is nerve, while computed tomography is preferred to a statistically independent prognostic risk factor for assess involvement of bone.16,17 Microscopically, there nodal metastasis (subhazard ratio, 2.2 [95% confidence is some debate as to what defines PNI. Suggested find- interval, 0.9-5.1]) and disease-specific death (subhaz- ings include the presence of cells inside the epineurium, ard ratio, 3.4 [95% confidence interval, 0.9-13.3]). involvement of nerves outside the main bulk of the Of interest, this increased risk applied only to PNI in tumor, or presence of tumor cells surrounding a nerve.18 nerves that were greater than 0.1 mm.24 These definitions have prognostic significance. Treatment Options—Management of confirmed Mendenhall et al16 found that patients with radiologic cases of cutaneous SCC with PNI is difficult because evidence of PNI without clinical symptoms had a of the nature of the lesions, including their increased higher cure rate using surgery and postoperative irra- propensity for metastasis, increased frequency of poorly diation compared to patients with clinical symptoms differentiated cell types, highly aggressive nature, and (80% vs 45%). Although prognosis generally is good the unique challenge of skip lesions.4,16 Skip lesions are in patients with cutaneous SCC without PNI, prog- found microscopically and show (or appear to show) nosis is notably poorer when PNI is present due to the neoplastic cells invading a nerve in a discontinuous association of this finding withCUTIS increased tumor recur- fashion. This phenomenon has been suggested as rence and both local and distant metastasis.13 Most fre- one explanation for the relatively higher postsurgical quently, cutaneous SCC with PNI spreads proximally, recurrence rate of SCC with PNI compared to lesions which can lead to invasion into the base of the brain, without PNI.7 They are of particular interest when but also can extend distally, leading to increased local removing cutaneous SCC with PNI using MMS and burden.12,19 In a study of 64 patients with mucosal SCC, attempting to define clear margins. Despite this limita- Soo et al20 found that patients with lesions that exhib- tion, MMS generally is accepted as the primary mode ited DoPNI had a 5-year survival Notof 16% versus 44% in of excisionCopy of cutaneous SCCs with PNI, as it has those without PNI. In their study of SCC of the head the highest known cure rate.7 Cottel4 did not report and neck, Goepfert et al14 reported that 46% (33/72) any cases of local recurrence over 1 to 42 months in of patients with PNI had died or were alive with recur- 17 patients who were treated with MMS, in contrast to rence at 2 years’ follow-up versus 9.1% (41/448) of Rowe et al25 who demonstrated that traditional surgical patients without PNI.
Load more

Recommended publications
  • State of Science Breast Cancer Fact Sheet
    Patient Version Breast Cancer Fact Sheet About Breast Cancer Breast cancer can start in any area of the breast. In the US, breast cancer is the most common cancer (after skin cancer) and the second-leading cause of cancer death (after lung cancer) in women. Risk Factors Risk factors for breast cancer that you cannot change Lifestyle-related risk factors for breast cancer include: • Drinking alcohol Being born female • Being overweight or obese, especially after menopause This is the main risk factor for breast cancer. But men can get breast cancer, too. • Not being physically active Getting older • Getting hormone therapy after menopause with As a person gets older, their risk of breast cancer estrogen and progesterone therapy goes up. Most breast cancers are found in women • Starting menstruation early or having late menopause age 55 or older. • Never having children or having first live birth after Personal or family history age 30 A woman who has had breast cancer in the past or has a • Using certain types of birth control close blood relative who has had breast cancer (mother, • Having a history of non-cancerous breast conditions father, sister, brother, daughter) has a higher risk of getting it. Having more than one close blood relative increases the risk even more. It’s important to know that Prevention most women with breast cancer don’t have a close blood There is no sure way to prevent breast cancer, and relative with the disease. some risk factors can’t be changed, such as being born female, age, race, and personal or family history of the Inheriting gene changes disease.
    [Show full text]
  • Skin Cancer 1
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Liberty University Digital Commons Running head: SKIN CANCER 1 Skin Cancer Causes, Prevention, and Treatment Lauren Queen A Senior Thesis submitted in partial fulfillment of the requirements for graduation in the Honors Program Liberty University Spring 2017 SKIN CANCER 2 Acceptance of Senior Honors Thesis This Senior Honors Thesis is accepted in partial fulfillment of the requirements for graduation from the Honors Program of Liberty University ______________________________ Jeffrey Lennon, Ph.D. Thesis Chair ______________________________ Sherry Jarrett, Ph.D. Committee Member ______________________________ Virginia Dow, M.A. Committee Member ______________________________ Brenda Ayres, Ph.D. Honors Director ______________________________ Date SKIN CANCER 3 Abstract The purpose of this thesis is to analyze the causes, prevention, and treatment of skin cancer. Skin cancers are defined as either malignant or benign cells that typically arise from excessive exposure to UV radiation. Arguably, skin cancer is a type of cancer that can most easily be prevented; prevention of skin cancer is relatively simple, but often ignored. An important aspect in discussing the epidemiology of skin cancer is understanding the treatments that are available, as well as the prevention methods that can be implemented in every day practice. It is estimated that one in five Americans will develop skin cancer during his or her lifetime, and that one person will die from melanoma every hour of the day. To an epidemiologist and health promotion advocate, these figures are daunting for a disease, especially for a disease that has ample means of prevention.
    [Show full text]
  • ABSTRACT Sensitivity and Specificity of Malignant Melanoma, Squamous Cell Carcinoma, and Basal Cell Carcinoma in a General Derma
    ABSTRACT Sensitivity and Specificity of Malignant Melanoma, Squamous Cell Carcinoma, and Basal Cell Carcinoma in a General Dermatological Practice Rachel Taylor Director: Troy D. Abell, PhD MPH Introduction. Incidence of melanoma and non‐melanoma skin cancer is increasing worldwide. Melanoma is the sixth most common cancer in the United States, making skin cancer a significant public health issue. Background and goal. The goal of this study was to provide estimates for sensitivity (P(T+|D+)), specificity (P(T‐|D‐)), and likelihood ratios (P(T+|D+)/P(T+|D‐)) for a positive test and (P(T‐|D+)/P(T‐|D‐)) for negative test of clinical diagnosis compared with pathology reports for malignant melanoma (MM), squamous cell carcinoma (SCC) , basal cell carcinoma (BCC), and benign lesions. This retrospective cohort study collected data on 595 patients with 2,973 lesions in a Central Texas dermatology clinic, randomly selecting patients seen by the dermatology clinic between 1995 and 2011. The ascertation of disease was documented on the pathology report and served as the “gold standard.” Hypotheses. Major hypotheses were that the percentage of agreement beyond that expected by chance between the clinicians’ diagnosis and the pathological gold standard were 0.10, 0.10, 0.30, and 0.40 for MM, SCC, BCC and benign lesions respectively. Results. For MM, the resulting estimates were: (a) 0.1739 (95% C.I. 0.0495, 0.3878), for sensitivity; (b) 0.9952 (95% C.I. 0.9920, 0.9974) for specificity; and (c) the likelihood ratios for a positive and negative test result were 36.23 and 0.83, respectively.
    [Show full text]
  • Actinic Keratoses Final Report
    Actinic Keratoses Final Report Mark Helfand, MD, MPH Annalisa K. Gorman, MD Susan Mahon, MPH Benjamin K.S. Chan, MS Neil Swanson, MD Submitted to the Agency for Healthcare Research and Quality under contract 290-97-0018, task order no. 6 Oregon Health & Science University Evidence-based Practice Center 3181 SW Sam Jackson Park Road Portland, Oregon 97201 May 19, 2001 Actinic Keratoses Structured Abstract Objective: To examine evidence about the natural history and management of actinic keratoses (AKs). Search Strategy: We searched the MEDLINE database from January 1966 to January 2001, the Cochrane Controlled Trials Registry, and a bibliographic database of articles about skin cancer. We identified additional articles from reference lists and experts. Selection Criteria: We selected 45 articles that contained original data relevant to treatment of actinic keratoses, progression of AKs to squamous cell cancer (SCC ), means of identifying a high-risk group, or surveillance of patients with AKs to detect and treat SCCs early in their course. Data Collection and Analysis: We abstracted information from these studies to construct evidence tables. We also developed a simple mathematical model to examine whether estimates of the rate of progression of AK to SCC were consistent among studies. Finally, we analyzed data from the Medicare Statistical System to estimate the frequency of procedures attributable to AK among elderly beneficiaries. Main Results: The yearly rate of progression of an AK in an average-risk person in Australia is between 8 and 24 per 10,000. High-risk individuals with multiple AKs have progression rates as high as 12-30 percent over 3 years.
    [Show full text]
  • Skin Cancers of the Feet: the Role of Today's Podiatrist in Detection And
    THE ROLE OF TODAY’S LEARN THE ABCDs OF PODIATRIST IN THE MELANOMA: DETECTION AND Here are some common attributes of MANAGEMENT OF SKIN cancerous lesions: DISEASE Asymmetry - If divided in half, the Podiatrists are uniquely trained as lower sides don’t match. extremity specialists to recognize and Borders - They look scalloped, treat abnormal conditions as they present uneven, or ragged. themselves on the skin of the lower legs Color - They may have more than and feet. Skin cancers in the lower extremity one color. These colors may have may have a very different appearance from an uneven distribution. those arising on the rest of the body. For Diameter - They can appear wider this reason, a podiatrist’s knowledge and than a pencil eraser (greater than clinical training is of extreme importance 6mm). for patients for the early detection of both benign and malignant skin tumors. For other types of skin cancer, look for Your podiatrist will investigate the spontaneous ulcers and non-healing sores, possibility of skin cancer both through bumps that crack or bleed, nodules with his/her clinical examination and with the rolled or “donut-shaped” edges, or discrete use of a skin biopsy. A skin biopsy is a scaly areas. simple procedure in which a small sample If you notice a mole, bump, or patch of the skin lesion is obtained and sent on the skin of a friend or family member to a specialized laboratory where a skin that meets any of these criteria, encourage Skin Cancers pathologist will examine the tissue in greater them to see an APMA member podiatrist detail.
    [Show full text]
  • What Are Basal and Squamous Cell Skin Cancers?
    cancer.org | 1.800.227.2345 About Basal and Squamous Cell Skin Cancer Overview If you have been diagnosed with basal or squamous cell skin cancer or are worried about it, you likely have a lot of questions. Learning some basics is a good place to start. ● What Are Basal and Squamous Cell Skin Cancers? Research and Statistics See the latest estimates for new cases of basal and squamous cell skin cancer and deaths in the US and what research is currently being done. ● Key Statistics for Basal and Squamous Cell Skin Cancers ● What’s New in Basal and Squamous Cell Skin Cancer Research? What Are Basal and Squamous Cell Skin Cancers? Basal and squamous cell skin cancers are the most common types of skin cancer. They start in the top layer of skin (the epidermis), and are often related to sun exposure. 1 ____________________________________________________________________________________American Cancer Society cancer.org | 1.800.227.2345 Cancer starts when cells in the body begin to grow out of control. Cells in nearly any part of the body can become cancer cells. To learn more about cancer and how it starts and spreads, see What Is Cancer?1 Where do skin cancers start? Most skin cancers start in the top layer of skin, called the epidermis. There are 3 main types of cells in this layer: ● Squamous cells: These are flat cells in the upper (outer) part of the epidermis, which are constantly shed as new ones form. When these cells grow out of control, they can develop into squamous cell skin cancer (also called squamous cell carcinoma).
    [Show full text]
  • Oculoplastic Aspects of Ocular Oncology
    Eye (2013) 27, 199–207 & 2013 Macmillan Publishers Limited All rights reserved 0950-222X/13 www.nature.com/eye Oculoplastic aspects C Rene CAMBRIDGE OPHTHALMOLOGICAL SYMPOSIUM of ocular oncology Abstract represents a significant proportion of the oculoplastic surgeon’s workload. In this review, It is estimated that 5–10% of all cutaneous the features of periocular skin cancer are malignancies involve the periocular region presented together with a discussion of the and management of periocular skin cancers treatment modalities. account for a significant proportion of the oculoplastic surgeon’s workload. Epithelial tumours are most frequently encountered, Diagnosing malignant eyelid disease including basal cell carcinoma, squamous cell carcinoma, and sebaceous gland Although malignant eyelid disease is usually carcinoma, in decreasing order of frequency. easy to diagnose on the basis of the history and Non-epithelial tumours, such as cutaneous clinical signs identified on careful examination melanoma and Merkel cell carcinoma, rarely (Table 1), differentiating between benign and involve the ocular adnexae. Although malignant periocular skin lesions can be non-surgical treatments for periocular challenging because malignant lesions malignancies are gaining in popularity, occasionally masquerade as benign pathology. surgery remains the main treatment modality For instance, a cystic basal cell carcinoma (BCC) 4,5 and has as its main aims tumour clearance, can resemble a hidrocystoma or sebaceous restoration of the eyelid function, protection gland carcinoma (SGC) classically mimics a 6,7 of the ocular surface, and achieving a good chalazion. Conversely, a benign lesion such as cosmetic outcome. The purpose of this article a pigmented hidrocystoma may be mistaken for 8 is to review the management of malignant a malignant melanoma.
    [Show full text]
  • An Uncommon but Often Lethal Skin Cancer Could Be That Individual Melanoma Patients Cancers Can Be Assessed by Gene Expression to Answer These Questions
    HEALTH in the US and Australia are successfully actions of vitamin D, genetic alterations CONCLUSION treated by early surgery. However, 10 in the gene that controls the vitamin D At this point, the role of genetics in percent of melanomas have been highly receptor or related genes might reasonably melanoma is still unclear. While intense, recalcitrant to treatment. In the quest for be associated with poorer survival from intermittent sun exposure is clearly better understanding, multiple investiga- melanoma. It may be that individuals who important in the etiology of melanoma, tors are evaluating the role of genetic factors have aggressive melanoma have a different its importance for survival is not known. in survival. While excessive, intermittent set of genetic mutations from those com- Therefore, one cannot reliably say whether sun exposure is an important risk factor mon in more indolent melanomas. nature or nurture (i.e., behavior) is more Merkel Cell Carcinoma: for melanoma, it does not appear to be as- The genetic factors associated with important in either the etiology or the sociated with poorer melanoma survival. melanoma progression and survival are progression of melanoma. Hopefully, this Thus, genetic factors may be the culprit; it still being explored. While genetics in other uncertainty will continue to spur research An Uncommon But Often Lethal Skin Cancer could be that individual melanoma patients cancers can be assessed by gene expression to answer these questions. JAYASRI IYER, MD, AND PAUL NGHIEM, MD, PHD with a particular constellation of inherited analyses from fresh tumor tissue, this is ex- genetic mutations are those who have tremely difficult in melanoma, as primary DR.
    [Show full text]
  • Merkel Cell Carcinoma: Update and Review Timothy S
    Merkel Cell Carcinoma: Update and Review Timothy S. Wang, MD,* Patrick J. Byrne, MD, FACS,† Lisa K. Jacobs, MD,‡ and Janis M. Taube, MD§ Merkel cell carcinoma (MCC) is a rare, aggressive, and often fatal cutaneous malignancy that is not usually suspected at the time of biopsy. Because of its increasing incidence and the discovery of a possible viral association, interest in MCC has escalated. Recent effort has broadened our breadth of knowledge regarding MCC and developed instruments to improve data collection and future study. This article provides an update on current thinking about the Merkel cell and MCC. Semin Cutan Med Surg 30:48-56 © 2011 Elsevier Inc. All rights reserved. erkel cell carcinoma (MCC) is a rare, aggressive, and current thinking, including novel insights into the Merkel Moften fatal cutaneous malignancy. It usually presents as cell; a review of the 2010 National Comprehensive Cancer a banal-appearing lesion and the diagnosis is rarely suspected Network (NCCN) therapeutic guidelines and new American at the time of biopsy. Because of increasing incidence and the Joint Committee on Cancer (AJCC) staging system; recom- discovery of a possible viral association, interest in MCC has mendations for pathologic reporting and new diagnostic escalated rapidly. codes; and the recently described Merkel cell polyoma virus From 1986 to 2001, the incidence of MCC in the United (MCPyV). States has tripled, and approximately 1500 new cases are diagnosed each year.1,2 MCC occurs most frequently among elderly white patients and perhaps slightly more commonly History in men. MCCs tend to occur on sun-exposed areas, with Merkel cells (MCs) were first described by Friedrich Merkel 3 nearly 80% presenting on the head, neck, and extremities.
    [Show full text]
  • Skin Cancer Protect Yourself: Know the Facts What Is Skin Cancer? What Are the Symptoms? Skin Cancer Begins When Cells That Skin Cancer Is Usually Not Painful
    skin cancer protect yourself: know the facts What is skin cancer? What are the symptoms? Skin cancer begins when cells that Skin cancer is usually not painful. The are not normal grow on the skin. Skin most common symptoms are a new cancer most often appears on the head, growth on the skin, a change in an old face, neck, hands and arms. Most skin growth, or a sore that does not heal. cancers appear after age 50, but the sun Not all skin cancers are the same. They damages the skin from early childhood. may look pale or red. They may feel crusty, flat, scaly, smooth or firm. The There are three types of skin cancer: first sign of melanoma is often a new basal cell, squamous cell, and melano- mole or a change in the size, shape, ma. The first two types are easy to cure color or feel of an existing mole. Most if found early. Melanoma is the most melanomas have a black or blue-black dangerous type. It can spread quickly area. to other parts of the body. If not treated, melanoma can result in death. How can I protect myself? • Stay out of the sun between What causes skin cancer? 10 a.m. and 4 p.m., whenever pos- Most skin cancers are caused by ul- sible. traviolet (UV) radiation. UV radiation • Wear long sleeves, long pants, and a comes from the sun, sunlamps and hat with a wide brim when you are tanning beds. People of all races can in the sun. get skin cancer, but those with fair skin • Choose wraparound sunglasses that and blonde or red hair are most at risk.
    [Show full text]
  • Non Melanoma Skin Cancer Pathogenesis Overview
    biomedicines Review Non Melanoma Skin Cancer Pathogenesis Overview Dario Didona 1, Giovanni Paolino 2, Ugo Bottoni 3 ID and Carmen Cantisani 2,* ID 1 Klinik für Dermatologie und Allergologie, Universitätsklinikum Marburg, Baldingerstraße, 35043 Marburg, Germany; [email protected] 2 Department of Dermatology, Sapienza Università di Roma, Rome 00100, Italy; [email protected] 3 Department of Dermatology, Università della Magna Grecia, Catanzaro 88100, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-064-997-6993; Fax: +39-0649-0243 Received: 16 November 2017; Accepted: 20 December 2017; Published: 2 January 2018 Abstract: (1) Background: Non-melanoma skin cancer is the most frequently diagnosed cancer in humans. The process of skin carcinogenesis is still not fully understood. However, several studies have been conducted to better explain the mechanisms that lead to malignancy; (2) Methods: We reviewed the more recent literature about the pathogenesis of non-melanoma skin cancer focusing on basal cell carcinomas, squamous cell carcinoma and actinic keratosis; (3) Results: Several papers reported genetic and molecular alterations leading to non-melanoma skin cancer. Plenty of risk factors are involved in non-melanoma skin cancer pathogenesis, including genetic and molecular alterations, immunosuppression, and ultraviolet radiation; (4) Conclusion: Although skin carcinogenesis is still not fully understood, several papers demonstrated that genetic and molecular alterations are involved in this process. In addition, plenty of non-melanoma skin cancer risk factors are now known, allowing for an effective prevention of non-melanoma skin cancer development. Compared to other papers on the same topic, our review focused on molecular and genetic factors and analyzed in detail several factors involved in non-melanoma skin cancer.
    [Show full text]
  • BASAL CELL CARCINOMA Basal Cell Carcinoma There Are 3 Major Types of Skin Cancer: Basal Cell Carcinoma, Squamous Cell Carcinoma and Melanoma
    The Power of Partnership » AP2.com Patient Education BASAL CELL CARCINOMA CELL BASAL Basal Cell Carcinoma There are 3 major types of skin cancer: basal cell carcinoma, squamous cell carcinoma and melanoma. The outer layer of the skin is made up of squamous cells. Below the squamous cells are the basal cells. Melanocytes, from which melanoma develops, are pigmented (sun-blocking) cells which are found in the lower and mid-level of the outer layer of the skin (epidermis). Background Information on Basal Cell Carcinoma Basal cell carcinoma is the most common type of skin cancer affecting nearly one million Americans each year. Incidence is higher in men than women, and tends to occur in older individuals, although rates are increasing in young adults and children. Most basal cell skin cancers can be cured, although individuals with these types of cancer have a higher risk for developing other skin cancers. Basal cell carcinoma occurs most frequently as a result of unprotected ultraviolet (UV) radiation exposure, either from sunlight or artificial sources such as tanning booths. Some of this exposure may have occurred recently, however, much of it may be due to exposures that happened many years earlier. Although this skin cancer rarely spreads to other organs of the body, it can cause destruction of surrounding tissue. Thus, early detection and treatment are needed. Early Indicators: It is important to be aware of the marks on your body, including moles, blemishes, freckles, etc. The American Cancer Society recommends checking your skin once a month to monitor any changes in these marks.
    [Show full text]